157 related articles for article (PubMed ID: 35578146)
1. Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride.
Zhang T; Li M; Han X; Nie G; Zheng A
AAPS PharmSciTech; 2022 May; 23(5):143. PubMed ID: 35578146
[TBL] [Abstract][Full Text] [Related]
2. CriticalSorb: a novel efficient nasal delivery system for human growth hormone based on Solutol HS15.
Illum L; Jordan F; Lewis AL
J Control Release; 2012 Aug; 162(1):194-200. PubMed ID: 22709592
[TBL] [Abstract][Full Text] [Related]
3. Enhanced brain distribution of Ginsenoside F1 via intranasal administration in combination with absorption enhancers.
Mao Y; Yuan W; Gai J; Zhang Y; Wu S; Xu EY; Wang L; Zhang X; Guan J; Mao S
Int J Pharm; 2024 Apr; 654():123930. PubMed ID: 38387820
[TBL] [Abstract][Full Text] [Related]
4. In vitro and preclinical assessment of an intranasal spray formulation of parathyroid hormone PTH 1-34 for the treatment of osteoporosis.
Williams AJ; Jordan F; King G; Lewis AL; Illum L; Masud T; Perkins AC; Pearson RG
Int J Pharm; 2018 Jan; 535(1-2):113-119. PubMed ID: 29038066
[TBL] [Abstract][Full Text] [Related]
5. [Effect of absorption enhancers on nasal ginsenoside Rg1 delivery and its nasal ciliotoxicity].
Chen XM; Zhu JB; Sun WD; Zhang LJ
Yao Xue Xue Bao; 2006 Feb; 41(2):149-55. PubMed ID: 16671546
[TBL] [Abstract][Full Text] [Related]
6. Performance and toxicity of different absorption enhancers used in the preparation of Poloxamer thermosensitive in situ gels for ketamine nasal administration.
Xia Y; Li L; Huang X; Wang Z; Zhang H; Gao J; Du Y; Chen W; Zheng A
Drug Dev Ind Pharm; 2020 May; 46(5):697-705. PubMed ID: 32293206
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats.
Na L; Mao S; Wang J; Sun W
Int J Pharm; 2010 Sep; 397(1-2):59-66. PubMed ID: 20599486
[TBL] [Abstract][Full Text] [Related]
8. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
Sinswat P; Tengamnuay P
Int J Pharm; 2003 May; 257(1-2):15-22. PubMed ID: 12711157
[TBL] [Abstract][Full Text] [Related]
9. Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts.
Tengamnuay P; Sahamethapat A; Sailasuta A; Mitra AK
Int J Pharm; 2000 Mar; 197(1-2):53-67. PubMed ID: 10704793
[TBL] [Abstract][Full Text] [Related]
10. [Influence of seven absorption enhancers on nasal mucosa--assessment of toxicity].
Zhao Y; Zhang DW; Zheng AP; Yu SY; Wu FL
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 36(4):417-20. PubMed ID: 15303139
[TBL] [Abstract][Full Text] [Related]
11. Methylated beta-cyclodextrins are able to improve the nasal absorption of salmon calcitonin.
Schipper NG; Verhoef JC; Romeijn SG; Merkus FW
Calcif Tissue Int; 1995 Apr; 56(4):280-2. PubMed ID: 7767838
[TBL] [Abstract][Full Text] [Related]
12. Non-ionic surfactants as novel intranasal absorption enhancers: in vitro and in vivo characterization.
Li Y; Li J; Zhang X; Ding J; Mao S
Drug Deliv; 2016 Sep; 23(7):2272-2279. PubMed ID: 25347689
[TBL] [Abstract][Full Text] [Related]
13. Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics.
Schipper NG; Verhoef JC; De Lannoy LM; Romeijn SG; Brakkee JH; Wiegant VM; Gispen WH; Merkus FW
Br J Pharmacol; 1993 Dec; 110(4):1335-40. PubMed ID: 8306072
[TBL] [Abstract][Full Text] [Related]
14. Intranasal toxicity of selected absorption enhancers.
Haffejee N; Du Plessis J; Müller DG; Schultz C; Kotzé AF; Goosen C
Pharmazie; 2001 Nov; 56(11):882-8. PubMed ID: 11817176
[TBL] [Abstract][Full Text] [Related]
15. The influence of absorption enhancers on nasal absorption of acyclovir.
Chavanpatil MD; Vavia PR
Eur J Pharm Biopharm; 2004 May; 57(3):483-7. PubMed ID: 15093597
[TBL] [Abstract][Full Text] [Related]
16. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.
Marttin E; Verhoef JC; Cullander C; Romeijn SG; Nagelkerke JF; Merkus FW
Pharm Res; 1997 May; 14(5):631-7. PubMed ID: 9165535
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.
Shao Z; Krishnamoorthy R; Mitra AK
Pharm Res; 1992 Sep; 9(9):1157-63. PubMed ID: 1409397
[TBL] [Abstract][Full Text] [Related]
18. The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa.
Asai K; Morishita M; Katsuta H; Hosoda S; Shinomiya K; Noro M; Nagai T; Takayama K
Int J Pharm; 2002 Oct; 246(1-2):25-35. PubMed ID: 12270606
[TBL] [Abstract][Full Text] [Related]
19. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of mucosal permeability enhancement of CriticalSorb® (Solutol® HS15) investigated in vitro in cell cultures.
Shubber S; Vllasaliu D; Rauch C; Jordan F; Illum L; Stolnik S
Pharm Res; 2015 Feb; 32(2):516-27. PubMed ID: 25190006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
